NCLT Orders Vivin Drugs and Laboratories CIRP Consolidation

NCLT Hyderabad orders substantive consolidation of CIRPs for Vivin Drugs & Pharmaceuticals and its subsidiary Vivin Laboratories.
The consolidation was approved by both CoCs due to entities' inseparable operations and shared 16-acre integrated pharmaceutical unit.
HDFC Bank, the lead creditor with a Rs 54.07 crore claim, filed the application to prevent value erosion and enable a feasible resolution.
The ruling cites Supreme Court precedent on CoC commercial wisdom and establishes a common asset pool and combined committee of creditors.